Efficacy and safety overview of a new inhaled corticosteroid, QVAR (hydrofluoroalkane-beclomethasone extrafine inhalation aerosol), in asthma
- 1 December 2000
- journal article
- review article
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 106 (6) , 1209-1226
- https://doi.org/10.1067/mai.2000.111582
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- Molecular pathology of allergic diseaseJournal of Allergy and Clinical Immunology, 2000
- Efficacy response of inhaled beclomethasone dipropionate in asthma is proportional to dose and is improved by formulation with a new propellantJournal of Allergy and Clinical Immunology, 1999
- Adrenal Effects and Pharmacokinetics of CFC-free Beclomethasone Dipropionate: a 14-Day Dose-Response StudyJournal of Pharmacy and Pharmacology, 1999
- Size Analysis of a Pressurized Metered Dose Inhaler–Delivered Suspension Formulation by the API Aerosizer Time-of-Flight Aerodynamic Particle Size AnalyzerJournal of Aerosol Medicine, 1999
- Small airways: a time to revisit?Thorax, 1998
- Inflammation of small airways in asthma☆☆☆★★★Journal of Allergy and Clinical Immunology, 1997
- Twenty-eight-day Double-blind Safety Study of an HFA-134a Inhalation Aerosol System in Healthy SubjectsJournal of Pharmacy and Pharmacology, 1996
- Variability of Airway Structure and Inflammation in Normal Subjects and in Cases of Nonfatal and Fatal AsthmaPathology - Research and Practice, 1996
- Safety of PropellantsJournal of Aerosol Medicine, 1995
- Clinical pharmacology of corticosteroids in bronchial asthmaPharmacology & Therapeutics, 1993